Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions Like Cancers, Autoimmune Conditions, Seizures and More For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to brand name drug companies hiking prices on 587 brand name drugs over the first two weeks of […]
Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments and Vaccines Ahead of Transition to Commercial Market For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday in response to reports that Moderna plans to hike the price of the company’s COVID-19 vaccine from $26.36 to […]
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging the American People at the Start of 2023 For Immediate ReleaseContact: Jon [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to reports brand name drug companies will hike prices on at least 350 prescription drugs to start the new year, […]
Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and More Out-of-Control Launch Prices on New Products For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to pharmaceutical companies CSL Behring and uniQure setting a $3.5 million price tag on […]
Drug Company Sets Nearly $200,000 Price on Newly Approved Treatment for Type 1 Diabetes, Blowing Past Wall Street Expectations For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to Provention Bio setting a $193,900 price tag for a course of treatment […]
Interchangeable Biosimilars Help Provide Patients with Greater Choice and More Affordable Alternatives to High-Priced Brand Name Drugs For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to the Food and Drug Administration’s (FDA) decision to approve interchangeable biologic drug Rezvoglar, as […]
Big Pharma Companies Want to Price-Gouge the American People and Health Care System as COVID-19 Vaccine and Therapeutic Coverage Shifts to Commercial Market For Immediate ReleaseContact: Jon [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to reports that brand name pharmaceutical giant Pfizer is planning to hike the price of the […]
Brand Name Drug Maker Amylyx Sets Price Tag For Relyvrio Between Five And 17 Times Estimates For A Fair Price Despite Lack Of Data on Efficacy For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to brand name drug maker Amylyx setting a list […]
Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to comments from some lawmakers suggesting a repeal of drug pricing solutions passed as part of the Inflation Reduction Act of 2022. “Washington finally […]
Big Pharma Giant Eyes Massive Price Hike on COVID-19 Vaccine Developed with $1.3 Billion Investment from American Taxpayers For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday reacting to reports that brand name drug company Moderna is considering hiking the price of the company’s COVID-19 vaccine as […]